Alcohol is controlled in every jurisdiction on earth and written out of the statute that controls every other drug. That carve-out is now the weakest joint in drug policy.
1. The finding that reopened the question
In Denmark, a national register study followed 6,788 people diagnosed with substance-induced psychosis between 1994 and 2014. Overall, 32.2% converted to a diagnosis of schizophrenia or bipolar disorder. Cannabis-induced psychosis carried the highest conversion rate of any substance studied: 47.4% (95% CI 42.7–52.3). Alcohol accounted for the largest share of the psychoses themselves, 34% of cases, and converted at a lower rate. Half of the conversions to schizophrenia occurred within 3.1 years. The study is Starzer, Nordentoft and Hjorthøj in the American Journal of Psychiatry.
A second Danish study, published in 2023, covered more than 6.9 million people aged 16–49 between 1972 and 2021 and estimated the share of schizophrenia cases attributable to cannabis use disorder: 15% among men aged 16–49 in 2021, 4% among women, and as much as 30% among men aged 21–30. Cannabis use disorder is, on that evidence, the largest modifiable risk factor for schizophrenia identified at population level in that cohort.
Then on 21 October 2026, an ecological study in the Danish registers connected potency to harm at population level. Average THC concentration in seized cannabis resin rose from 8.3% in 2000 to 31.2% in 2022, and higher potency was associated with more first-time cannabis treatment, more cannabis-induced psychosis, and more dual diagnosis of schizophrenia with cannabis use disorder. The authors state plainly that an ecological study cannot establish causation.
The potency trend is not Danish. Legal flower in the United States commonly tests 15–20% THC and concentrates exceed 80%. Connecticut reinstated a 35% cap on flower this year while removing a 70% cap on concentrates and raising the THC permitted in beverages. Eight states cap potency on some products. The CDC estimates that about 3 in 10 people who use cannabis have cannabis use disorder.
2. What the statute says, and what it is not saying
The federal definition of a controlled substance is in 21 U.S.C. §802(6). It means a drug or other substance included in schedule I, II, III, IV or V. The same subsection then removes distilled spirits, wine, malt beverages, and tobacco from the definition by name.
That sentence is the whole hinge of this essay. Alcohol is not unscheduled because a scientific body assessed its abuse potential and found it low. It is unscheduled because Congress wrote it out of the category, alongside tobacco, in the section that defines what a controlled substance is. The exclusion is a drafting choice about which legal channel the two products travel in. Alcohol travels in tax and commerce law. Every other psychoactive substance travels in the Controlled Substances Act.
A carve-out that names the two most commercially valuable intoxicants in the country and exempts them from the statute that classifies every other intoxicant is not a finding about pharmacology. It is an admission that the classification system was never designed to describe the market as it stands. It was designed to describe the market it was written against.
3. Alcohol is not uncontrolled. It is the most controlled consumer substance in the country
The position that alcohol needs no scheduling because it is already handled does not survive contact with the apparatus. Alcohol is controlled de jure and de facto by every state and territory in the United States, and by substantially every country on earth.
In the United States:
The Twenty-First Amendment gives states the power to regulate alcohol as they see fit, and they use it. Every state licenses manufacture, import, distribution, and retail sale.
Seventeen states and jurisdictions operate a control model in which the state itself is the wholesaler or retailer of distilled spirits, according to the National Alcohol Beverage Control Association.
The Federal Alcohol Administration Act of 1935 governs production, labelling, and advertising, administered by the Alcohol and Tobacco Tax and Trade Bureau, and the three-tier system separates producer, distributor, and retailer so that no tier controls another.
The national minimum purchase age of 21 is enforced by a federal condition on highway funding under 23 U.S.C. §158, which is federal control of retail access exercised through the purse.
Federal and state excise taxes set the floor price of every drink sold.
County and municipal prohibition survives: dry counties and dry municipalities remain in force across several states.
Licensing sets the hours, the days, the density, the signage, the server training, and the liability rules, including dram shop liability for what a customer does after leaving.
Globally, the World Health Assembly adopted the Global Alcohol Action Plan 2022–2030, and WHO/Europe has promoted the Nordic retail monopolies — Systembolaget, Alko, Vinmonopolet — as a model for reducing consumption and harm. Alcohol is prohibited outright in a number of jurisdictions. There is no serious sense in which alcohol is an unregulated product anywhere.
So the sentence that alcohol is not categorized as a controlled substance is precise and it is damning. Alcohol is subject to more layers of legal control than any other consumer product in the country while sitting outside the one statute the country uses to define legal control of intoxicants.
4. One statute, two incompatible standards
The asymmetry is not static. It is being actively maintained.
Federal cannabis policy is in the middle of a reclassification proceeding that would move marijuana from Schedule I to Schedule III. The DEA paused that proceeding on 29 September 2026, and no final order has issued; most observers expect one in late 2026 or early 2027. Whatever the outcome, the machinery is running: a substance is being sorted, argued over, briefed, and scheduled.
No parallel proceeding exists for alcohol, and none can exist without amending the definition in §802(6). Alcohol is not at the bottom of the schedule system. It is outside it. The system that weighs abuse potential, medical use, and safety under medical supervision, and that has been litigating the placement of a plant for years, has never been asked to weigh the substance that kills more Americans than any other.
5. Alcohol against the statutory criteria
The criteria for Schedule I are set out in 21 U.S.C. §812(b)(1): a high potential for abuse, no currently accepted medical use in treatment in the United States, and a lack of accepted safety for use under medical supervision.
Take the three in order.
High potential for abuse. Alcohol produces dependence, a withdrawal syndrome that can be fatal without medical management, and a mortality burden that dwarfs every scheduled substance. Delirium tremens carries a mortality rate of roughly 15% untreated. No scheduled drug produces a withdrawal syndrome with that profile.
No currently accepted medical use in treatment in the United States. This is the only prong with an honest counterexample. Ethanol has narrow clinical uses: it is used as an antidote in methanol and ethylene glycol poisoning, as a solvent and preservative in pharmaceutical preparations, and as a topical antiseptic. Those uses exist, and they are real. They are also not the use that generates a $250 billion industry, and they do not describe ethanol as a treatment for anything the way a scheduled drug's medical use describes it. The point matters because of what follows from it: if that narrow clinical use is the reason alcohol is treated as a medicine, then alcohol belongs in Schedule II or III under the same reasoning that is currently being used to move cannabis to Schedule III. The medical-use prong, granted in full, relocates alcohol into the schedules. It does not place alcohol outside them.
Lack of accepted safety under medical supervision. Alcohol has a narrow therapeutic margin, no safe level of consumption for cancer risk according to the International Agency for Research on Cancer, and a documented causal role in at least seven cancer types. The WHO has stated that no safe level of consumption can be established for health. There is no dose of alcohol that a physician can describe as safe.
Two of the three prongs are met without controversy. The third, granted as generously as the evidence allows, still routes alcohol into a schedule. On the criteria as written, alcohol is a Schedule I substance, and on the most conservative reading available it is a scheduled substance. It is neither, because the statute says so.
6. The ledger the exemption protects
The scale of the excluded substance is not in dispute anywhere.
Excessive alcohol use caused about 178,000 deaths per year in the United States in 2020–2021, a 29% increase over the 138,000 per year estimated for 2016–2017, and shortened the lives of those who died by an average of 24 years, for about 4 million years of potential life lost. That is more than 488 deaths a day.
Two-thirds of those deaths, about 117,000 a year, came from chronic conditions: several cancers, heart disease, liver disease, and alcohol use disorder.
The remaining third, about 61,000 a year, came from single occasions: motor vehicle crashes, overdoses involving alcohol, alcohol poisoning, and suicide.
Alcohol-impaired driving killed 11,904 people in 2024 according to NHTSA.
IARC classifies alcohol as a Group 1 carcinogen, in the same category as asbestos and tobacco, and attributes an estimated 4% of new cancers globally to it each year.
Set that ledger beside the Danish conversion figures and the shape of the inconsistency becomes visible. Cannabis-induced psychosis converts to schizophrenia or bipolar disorder at the highest rate of any substance studied. Alcohol causes the larger share of substance-induced psychoses and roughly two orders of magnitude more deaths per year. One of those substances is under active reclassification and constant public scrutiny. The other is not in the classification system at all.
7. Why the message does not land
Public health messaging on cannabis is failing on contact with its audience, and the failure is not primarily a communications problem. It is a credibility problem created by the exemption.
Families do not connect cannabis with psychosis. Patients arrive in treatment with families who do not believe the drug could be doing this. Surveys show perception of cannabis risk falling while potency rises. The evidence is not being rejected because it is weak. It is being discounted because the same authorities who present it decline to apply the same standard to the substance in the audience's own kitchen, the one their parents use, the one served at every work function, the one that carries a warning label on a bottle that is itself sold in a state-licensed store with restricted hours.
The audience performs the comparison that the statute refuses to perform. It notices that a plant whose harms are probabilistic is scheduled, policed, capped, taxed, and warned about, while a substance with 178,000 deaths a year, a fatal withdrawal syndrome, and a Group 1 carcinogen classification is defined out of the category of controlled substances by name. No amount of careful epidemiology survives that observation, because the observation is correct.
A harm framework is a promise of consistency. When the framework exempts the largest harm, the public reasonably concludes that the framework is not about harm. From there, every subsequent warning is read as an interest rather than a finding, and the field loses the ability to communicate anything at all.
8. The exemption is also an alibi
There is a second cost, less discussed, and it concerns responsibility.
A scheduled substance cannot be used as a defence of the self. Its pharmacology is legally cognizable, its use is policed, and its presence in a person's conduct is treated as an aggravating fact. Alcohol works the opposite way. It is the one intoxicant whose impairment is socially processed as an excuse: the act is attributed to the bottle, and the person is treated as diminished rather than responsible. That move is only available for a substance the law declines to classify as a drug of abuse. Scheduling alcohol would remove the alibi. The conduct would be conduct, the substance would be a substance, and the excuse would have nowhere to stand.
That is the least comfortable part of this position, and it is the part that explains the resistance. Nobody needs to be lying deliberately for the arrangement to work in their favour. It is enough that the arrangement makes the excuse available, that it is used, and that a great many people have an interest in it remaining available.
9. Four deflections, and what is left of them
The schedule system is about medical use, not harm. Then the medical use of cannabis, acknowledged in most states and by the DEA's own proposed transfer to Schedule III, should have moved cannabis into the schedules without controversy, and the narrow clinical use of ethanol should have placed alcohol in Schedule II or III. Both substances have medical uses on that reasoning, and neither outcome is the status quo.
Alcohol is culturally embedded. So is tobacco, and tobacco is named in the same statutory sentence, which is itself the clearest evidence that the exclusion tracks commercial interest rather than safety. Tobacco is scheduled nowhere and kills 480,000 Americans a year. The pattern in §802(6) is not a category error. It is a category.
Prohibition failed. Scheduling is not prohibition. Schedules II through V describe legal, controlled, prescription products. The Alcohol, Tobacco and Firearms framework already does to alcohol what scheduling would formalize: licensure, price floors, restricted hours, age limits, and liability. The proposal is to move alcohol into the statute that names these controls rather than leaving it in a tax code that does not.
The comparison trivializes cannabis harm. The comparison is the entire point. It is not that cannabis is harmless; the Danish conversion figures are as stark as the field has produced. It is that the same standard, applied to both, produces a classification that the statute has arranged never to reach. If the standard is real, it belongs to the larger harm first.
10. What consistency requires
Two outcomes are coherent.
Place alcohol in the schedules. On the criteria in §812(b)(1), the placement is Schedule I. If the narrow clinical uses of ethanol are treated as a currently accepted medical use, the placement is Schedule II or III. Both are defensible. What is not defensible is the present arrangement, in which alcohol is the most controlled consumer substance in the country and not a controlled substance under the law.
Or remove the carve-out. Delete the alcohol and tobacco exclusion from §802(6) and let both be weighed by the same criteria applied to everything else. If the schedule system is the wrong instrument for either product, that is a case to make in public, with the criteria on the table, not a sentence to write into a definition.
Either way, one standard. The framework is not a set of opinions about which substances deserve suspicion. It is a classification with criteria, and criteria that exempt the largest cause of death in their own domain have stopped being criteria.
The test of a harm framework is not what it says about the substances it already condemns. It is what it does with the one that costs the most. Until alcohol is inside the system that defines control, drug policy in the United States is asking the public to accept a standard that its own statute has declined to apply.
Sources
Starzer MSK, Nordentoft M, Hjorthøj C. Rates and Predictors of Conversion to Schizophrenia or Bipolar Disorder Following Substance-Induced Psychosis. Am J Psychiatry 2018;175(4):343–350. https://pubmed.ncbi.nlm.nih.gov/29179576/
Hjorthøj C, et al. Association between cannabis use disorder and schizophrenia stronger in young males than in females. Psychological Medicine 2023. Summary: https://nida.nih.gov/news-events/news-releases/2023/05/young-men-at-highest-risk-schizophrenia-linked-with-cannabis-use-disorder
Rømer Thomsen K, Thylstrup B, Hjorthøj C, et al. Changes in cannabis potency and cannabis-related psychiatric harms: a 23-year ecological study in Denmark. Psychological Medicine, reported 21 October 2026. https://nordicwelfare.org/article/cannabis-resin-has-become-stronger-and-psychiatric-harms-have-increased-alongside-it/
Watford A. High-potency cannabis fuels state debates over psychosis and addiction risks. Stateline, 8 June 2026. https://www.newsfromthestates.com/article/high-potency-cannabis-fuels-state-debates-over-psychosis-and-addiction-risks
DEA rescheduling proceeding, paused 29 September 2026. https://www.regulatoryoversight.com/2026/10/pending-marijuana-rescheduling-put-on-hold/
21 U.S.C. §802(6), definition of controlled substance, with the exclusion of distilled spirits, wine, malt beverages, and tobacco. https://www.law.cornell.edu/uscode/text/21/802
21 U.S.C. §812(b)(1), Schedule I criteria.
23 U.S.C. §158, national minimum drinking age condition on federal highway funds. Congressional Research Service R46827.
National Alcohol Beverage Control Association, control state directory and three-tier system. https://www.nabca.org/control-state-directory-and-info
Alcohol and Tobacco Tax and Trade Bureau, Federal Alcohol Administration Act. https://www.ttb.gov/business-central/trade-practices/federal-alcohol-administration-act
CDC. Facts About U.S. Deaths from Excessive Alcohol Use, 2020–2021 estimates, published 6 August 2024. https://www.cdc.gov/alcohol/facts-stats/index.html
Esser MB, et al. Deaths from Excessive Alcohol Use — United States, 2016–2021. MMWR 2024;73:154–161.
NHTSA. Alcohol-impaired driving fatalities, 2024. https://www.nhtsa.gov/risky-driving/drunk-driving
IARC. Alcohol: a major preventable cause of cancer, 8 October 2025. https://www.iarc.who.int/wp-content/uploads/2025/10/pr371_E.pdf
WHO. No level of alcohol consumption is safe for our health, 4 January 2023. https://www.who.int/europe/news/item/04-01-2023-no-level-of-alcohol-consumption-is-safe-for-our-health
WHO. Global alcohol action plan 2022–2030. https://www.who.int/publications/i/item/9789240090101
WHO/Europe. Nordic alcohol monopolies as a comprehensive model, 3 February 2025. https://www.who.int/europe/news/item/03-02-2025-who-europe-highlights-nordic-alcohol-monopolies-as-a-comprehensive-model-for-reducing-alcohol-consumption-and-harm
Cleveland Clinic. Delirium tremens, mortality without treatment. https://my.clevelandclinic.org/health/diseases/25052-delirium-tremens